November 2011 -- For any company who is looking to grow their business in the Far East especially in Indonesia then InaPharm or InaChem is the place to be in July 2012.
The premier B2B trade fair dedicated to the pharmaceutical industry in Indonesia, InaPharm is a three day industry event running alongside the 2nd edition of InaChem - the Indonesia International Chemical Exhibition and Chemical Engineering Conference. InaChem is the largest chemical industry event in Indonesia and focuses on a diverse range of chemical, analytical and process engineering technologies. InaChem featured 130 exhibitors at the 2010 event and attracted more than 4,500 high-calibre visitors from 13 countries. InaPharm will offer European organizations unlimited deal making and networking opportunities as well as a chance to meet with producers, processors, technology suppliers and consumers across the entire value chain of the Indonesian pharmaceutical industry.
In 2010 Indonesia’s pharmaceutical market value was estimated to be worth Rp 37,52 trillion (US$4,1billion). The industry is projected to grow by 12 to 14 % in the coming years and forecast to be the sixth largest pharmaceutical market in the Asia Pacific region by 2016.
InaPharm, the Indonesia International Pharmaceutical Ingredients Manufacturing & Technology Expo, has appointed marketing communications specialist, Phoenix MarCom of Cambridge, UK, as its exclusive European agency to promote InaPharm’s event in 2012 to European companies. Phoenix MarCom, which is also exclusive European agent for InaPharm’s sister Indonesian event InaChem, is capable of delivering a wide variety of support services and marketing expertise to any European based exhibitors that sign up for either event.
“Almost 90% of Indonesia’s pharmaceutical raw materials are imported from overseas – mainly from China, India, US and Europe,” explained Malcolm Lee, Phoenix MarCom’s business development manager. “For 2011-12, investment in the Indonesian pharmaceutical sector is targeted to grow by 50% to 60% from US$500 million to US$750 - 800 million as a result of the Indonesian Government’s policy to give more opportunity for foreign ownership. The policy aims to help Indonesia become a globally significant production base for international pharmaceutical manufacturing companies.” “At this moment, Indonesia is one of the few growth areas worldwide which makes both InaPharm and InaChem ideal events for European companies who are looking to expand into the South East Asian region. An added attraction for European businesses is the highly cost effective booth space being offered by both events so it is wise to book a booth as soon as possible to ensure participation in these key events. Both shows are supported by excellent regional media coverage that is going to attract large numbers of potential customers in what is promising to be a very large, vibrant market.”
